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Telemedicine for Outpatient Neurosurgical Oncology Care: Lessons Learned for the
Future During the COVID-19 Pandemic
Lekhaj C. Daggubati1, Daniel G. Eichberg2, Michael E. Ivan2,3, Simon Hanft4, Alireza Mansouri1,5, Ricardo J. Komotar2,3,
Randy S. D’Amico6, Brad E. Zacharia1,5

BACKGROUND: The coronavirus 2019 (COVD-19)
pandemic has drastically disrupted the delivery of
neurosurgical care, especially for the already at-risk
neuro-oncology population. The sudden change to
clinic visits has rapidly spurned the implementation of
telemedicine. A recommendation care paradigm of
neuro-oncologic patients limited by telemedicine has
not been reported.

-

METHODS: A summary of a multi-institution experience
detailing the potential benefits, pitfalls, and the necessary
considerations to outpatient care of neurosurgical
oncology patients.

INTRODUCTION

T

he emergence of the novel coronavirus disease 2019
(COVID-19) has drastically impacted the delivery of medical care worldwide. Its long incubation period, high
transmission rate, and estimated 3% mortality has quickly made it
a global pandemic.1,2 As physical distancing measures take hold
and medical resources are directed toward COVID-19, the traditional patient physician visit has been revisited with the rapid
acceleration of telemedicine.

-

RESULTS: There are limitations and advantages to
incorporating telemedicine into the outpatient care of
neuro-oncology patients. Telemedicine-specific considerations for each step and stakeholder of the appointment
(physician, patient, scheduling, previsit, imaging, and
physical examination) are examined.

-

CONCLUSIONS: Telemedicine, pushed to prominence
during this COVID-19 pandemic, is a powerful and possibly
preferential tool for the future of outpatient neurooncologic care.

-
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TELEMEDICINE DURING THE COVID-19 PANDEMIC
An emerging technology for more than 25 years, telemedicine uses
electronic and digital platforms to exchange medical information
for improved consumer health. Widespread use had been
restricted, in part, by limitations in reimbursement,2-5 which
curtailed the adoption for clinic visits. The abrupt disruption of
in-person medical care by COVID-19, however, has forced the
Centers for Medicare & Medicaid Services to provide an emergency
waiver for telemedicine as billable consultations. Codes
99201 99215 for outpatient telemedicine visits were approved into
Medicare within days of the federal state of emergency
announcement.6 In addition to established patients, the waiver
allows for new patient consultations to be billed with these
codes. Historically resistant, but currently mobilized by the
COVID-19 pandemic, some of the largest health insurance providers (Aetna, Cigna, and Humana) have announced telehealth
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reimbursement to parallel the evolving Centers for Medicare &
Medicaid Services reimbursement structure.7 The reimbursement
structure of private insurances still vary on a state level, and
local guidelines should be reviewed by practitioners. Before this,
neurosurgical use of telemedicine has been limited, albeit
extremely successfully, to telestroke programs.8 Its use in
neurosurgical oncology has been limited to institutional
collaborations, rehabilitation, and psychological support.9-12 This
knowledge gap poses a challenge to optimal delivery of outpatient
care, particularly in the current pandemic. Given our institutions’
early adoption of telemedicine, we summarize the necessary capabilities and recommendations for the incorporation of telemedicine in outpatient surgical neuro-oncology sparked by the
COVID-19 pandemic, with the expectation that this technology
continues to be optimized and used beyond this period.
PATIENT-SPECIFIC ADVANTAGES OF TELEMEDICINE IN
NEUROSURGICAL ONCOLOGY
The current recommendations for neuro-oncology during the
COVID-19 pandemic have focused on disease prioritization,
inpatient management, and health care worker protection.13-16
Consensus regarding optimal evaluation of new patients and
established follow-up has yet to be reached. In these rapidly
changing times, approaches have included limiting visits to urgent
patients only, incorporating telemedicine, and complete cancellation of outpatient neurosurgery clinics. With limited previous
experience, lessons learned in telemedicine practices adopted
during this pandemic will dictate protocols for neuro-oncology in
the future.
Especially critical during the COVID-19 pandemic, telemedicine
visits reduce external exposure of these immunocompromised
patients, family, care partners, and staff. For individuals with a
neuro-oncologic diagnosis, challenges before the pandemic have
included neurologic impairments—often requiring accompaniment by care partners—and long-distance travel for tertiary
neurosurgical oncology care. Thus, the availability of telemedicine
capabilities presents a clear advantage for these individuals, as it
facilitates complete consultations and follow-up visits from the
comfort of their homes. Although legislation does not currently
allow multiple subspecialty practitioners to bill simultaneously for
a visit, patient care-teams of various subspecialties may be
consolidated into consecutive appointments to optimize patientcentered care. This reduces total time dedicated to the appointments as well as unnecessary wait times, which are frequently
quoted as the worst components of a clinic visit.17,18 In addition,
telemedicine can decrease reliance on care partners. Current inperson appointments can present a unique cost to the patient
and family though care partner loss of productivity during the
appointment and external transport services.17-19 Moreover, telemedicine offers unparalleled ﬂexibility; care partners can be either
at the patient’s side or physically distant and easily be conferenced
via voice or video into the visit.
LIMITATIONS OF TELEMEDICINE IN NEUROSURGICAL ONCOLOGY
Despite the clear advantages of telemedicine, concerns remain
regarding adverse effects to patient privacy, physician patient
relationship, and completion of a thorough physical and
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neurologic examination. Telemedicine is an obstacle for those
with limited access to telemedicine platforms and experience with
Internet-based technologies. The proliferation of smartphone
ownership, improved broadband coverage, and a technologically
adapt population has broken down the traditional barriers to
telemedicine. In the long run, the beneﬁts of providing telemedicine services to neuro-oncology patients likely outweigh these
limitations, but studying the effects on patient outcome and
patient provider satisfaction will be paramount. We encourage a
thoughtful approach to the continuous evaluation of telemedicine
in the neuro-oncology patient to ensure optimal patient care.
TELEMEDICINE PLATFORMS
Synchronous platforms allow for the patient and the neurosurgery
team (physician, advanced practice clinician, nurse, resident, and/
or fellow) to connect at the same time, whereas asynchronous
platforms afford distant electronic communication and monitoring at different times. Asynchronous forms of telemedicine,
including e-mail and secure messaging, have been increasingly
used, but the rapid expansion of video conferencing capabilities
and smartphones have paved the way for synchronous forms of
telemedicine. The current platforms available range from simple
telephone voice conferences to more immersive video conferencing. Although billing waivers allow for voice-only telephone
visits, the inability to perform a neurologic examination and lack
of direct patient provider visualization is limiting. We feel these
should be reserved for the most routine follow-up visits when
alternative means are not feasible. Video conferencing affords
improved communication, the ability to perform a reasonable
neurologic examination, sharing of imaging directly with the patient, and likely leads to a better rapport and patient satisfaction.
We foresee a rapid rise of platforms as telemedicine becomes an
established option. There are important criteria that each system
must fulﬁll before enabling safe medical alternatives. Although
relaxed regulations during the current COVID-19 pandemic allow
non-Health
Insurance
Portability
and
Accountability
Act compliant interfaces (i.e., Facetime),20 we strongly
recommend the transitioning to a Health Insurance Portability
and Accountability Act compliant platform (i.e., OhMed, Doxy.me, American Well, Mend, VSee) for the continued use of
telemedicine following the COVID-19 crisis.21 Useful additional
features offered include E-prescribing capabilities, billing
capabilities, integration with internal electronic health records
(EHRs), and digital patient intake. Blood work, medications,
and imaging orders will remain similar to in-person visits; they
will be ordered electronically via the EHR and communicated
directly to the patient.
Vital to neuro-oncologic disease evaluation, neuroimaging
needs to be available for comprehensive care. Current standard
practice is in-system imaging before a clinic visit. Although varied
by region, the COVID-19 pandemic has likely decreased overall
neurosurgical oncology visits and has limited access to timely
imaging. Patient triage is being performed on a case-by-case basis,
and those requiring urgent imaging evaluation have not been
delayed. Noncritical, benign surveillance imaging, however, has
been rescheduled for patient safety and optimization of resource
use. Patients also may obtain imaging at centers closer and more
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convenient to their homes and transfer the images to their
physician before the appointment. This is most often completed
via mail, but cloud-based secure imaging systems are becoming
more commonplace. In addition, incorporation of imaging onto a
shared screen during the appointment, offered by many platforms,
improves patient satisfaction and understanding of the pathology
and plan.
BEST PRACTICES: RECOMMENDATIONS FROM THE COVID-19
PANDEMIC
The following best practices discussed in this section are also
shown in Table 1.
Scheduling
New consultations and transitioning patients to telemedicine visits
should be contacted by ofﬁce staff to conﬁrm willingness to
participate in a virtual visit and that the patient’s software and
hardware meet the necessary requirements for the proposed
platform. Patients are notiﬁed that these visits are billable to
Table 1. Checklist for Optimized Outpatient Neuro-Oncology
Telemedicine Visits
Previsit
Previsit forms, imaging, and outside medical records are available for
review
Review imaging for high-risk, unstable patients
Use telephone appointments as a last resort
Setting
Provider

Patient

Professional, clean, and well-lit office

Well-lit and large setting

No background noises

No background noises

Secure setting

If needed, care partner or
family present

Physical examination and imaging (Table 2)
Pay attention to red flags (decreased arousal, unsecure airway, significant/
disproportionate mass effect, and hydrocephalus)
Visit
Confirm patient consent for telemedicine visit
Build rapport
Focused clinical history
Focused physical examination
Imaging review with patient
Plan of care/surgery
Documentation and billing
Limitations
Detailed physical examination
Lack of telemedicine accessibility
Patient preference
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insurance and they will incur a co-pay similar to an in-person visit.
Patients who are unable to complete a video-based visit and
require wound evaluation should be instructed to provide digital
pictures, if possible. Patients with concerning neurologic or imaging ﬁndings should be referred to the medical staff for an
additional screening. Those with urgent clinical or imaging ﬁndings (hydrocephalus, hemorrhagic lesions causing signiﬁcant
acute mass effect, signs of decreased arousal or concern for airway
protection) should be directed for urgent evaluation. Thus, telemedicine encounters should be thoroughly screened for patients
who can be managed remotely.
Previsit Preparation
Before the appointment, all backend administrative procedures
should be completed by the appropriate ofﬁce staff. All patient
imaging and documentation should be available and reviewed by
the physician. Selecting cloud-based imaging and intake platforms
that readily integrate with native EHRs and hospital technologies
would enable the most optimal workﬂow. These steps are aimed
at preventing unnecessary technical delays and affording appropriate time during the televisit.
Provider/Patient Setting
The role of the provider is to offer a professional, safe, and private
environment to discuss potentially serious and life-altering pathology. The provider should select a well-lit and clean ofﬁce for
the appointment with minimal external noise or distractions.
In turn, the patient should do likewise in terms of lighting and
noise. The patient also can plan space for actions that would
replace a traditional physical examination. Care partners and/or
family also should be available if needed/wanted to streamline the
appointment. If the patient has underlying neurologic issues that
limit their understanding or ability for self-care, a care partner is
necessary during the visit. Translators from home, or traditional
translator services, can be incorporated as necessary. These instructions can be provided to the patient during scheduling.
Physical Examination
A potential weakness of telemedicine is the neurologic examination. The provider is limited to observable actions such as coordination, gait, tremor, and gross elicitable actions. Several studies,
however, have validated the neurologic examination in telemedicine.22,23 The National Institutes of Health Stroke Scale is a
standardized and replicable neurologic examination (Table 2)
and satisﬁes many of the relevant neurologic examinations for a
neuro-oncology patient.24-27 For skull-base tumors, a more elicitable cranial nerve examination is recommended. Anisocoria can
be seen with a close-up of the patient’s eyes, whereas reaction
could be crudely examined via the care partner’s assistance with a
ﬂashlight, but a detailed pupillary evaluation is limited. If critical
for decision-making, the patient should be requested to have an
in-person visit. For preoperative patients, a thorough examination
should be documented before surgery on the day of surgery. For
spinal oncology patients, a more thorough examination may
necessitate an in-person evaluation or assistance from a caregiver/
family member. When limited to portions of the National Institutes of Health Stroke Scale or observable tasks, telemedicine
can provide the basic elements of a neurologic examination.
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Table 2. Neurologic Examination Components Assessable
During Telemedicine Visit
Mentation

Extremities

Level of consciousness

Gross strength (antigravity/drift)

Memory assessment

Sensation (with care partner/
family)

Ability to follow tasks

Muscle bulk*

Face examination

Tremor*

Extraocular movements

Gait*

Visual fields and anisocoria
(with care partner/family)
Facial palsy

Coordination

Hearing (with care partner/
family or phone)

Dysdiadochokinesia*

Shoulder shrug*

Heel-to-knee or finger-to-nose
(with care partner/family)*

Tongue movement*

Walk-on-toes*

Language

Walk-on-heel*

Aphasia

Romberg test (with care partner/
family)*

Dysarthria
The components were tabulated from relevant National Institutes of Health Stroke Scale
(NIHSS) tests and observable tests.
*The components are observable tests not included in the NIHSS. The test should be used
as necessary for the particular pathology.

Ultimately, provider discretion is required to determine when a
more detailed face-to-face examination is warranted.
Documentation and Billing
Telehealth visits require the physician document patient consent
to the virtual appointment and billing, date of the visit, the
location of the provider and the patient, and the amount of time
spent face-to-face. Currently, codes 99201 99205 allows for new
outpatient visits, whereas 99211 99215 apply for established patient visits. Care should be taken to ensure the appropriate
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focused documentation to facilitate unambiguous billing and
reimbursement. For voice-only televisits, time documentation is
required. For visits with the addition of video, standard evaluation
and management coding requirement should be followed.
PLANNING FOR THE FUTURE
The current pandemic will end, and we need to ensure appropriate
measures are taken for continued growth of telemedicine. We
believe that as the country opens up, we will begin to see a cohort
of patients who have relatively late tumor presentation secondary
to a variety of factors at play during the pandemic, including
limited primary care and emergency department visits, reluctance
to pursue medical evaluation for insidious symptoms, and concerns regarding ﬁnances and family safety. The permanent
establishment of current temporary waivers will be critical for the
sustained adoption of telemedicine. Beyond Medicare/Medicaid,
private insurances will need to reimburse these codes for widespread adoption. The natural evolution of technology hastened by
the pandemic-induced focus on remote connectivity will continue
the proliferation of high-speed Internet, smart devices, and patient familiarity. To this end, many hospital systems and practices
have begun devoting substantial effort to get patients “up to
speed” regarding telemedicine. Although telemedicine will never
be appropriate for all patients and all conditions, we believe it will
continue to play a signiﬁcant role in neurosurgical oncology long
after the virus is gone.
CONCLUSIONS
The COVID-19 crisis has forced all of medicine, including neurosurgery, to rapidly incorporate telemedicine into standard clinical
care. Rushed to adoption, there are beneﬁts and limitations in
neuro-oncologic patients that a neurosurgeon must understand.
We believe that telemedicine will remain integral to the care of
neuro-oncology patients, well past the COVID-19 pandemic. It is
vital that the current waiver allowing telemedicine reimbursements
should continue unhindered. There is no doubt that telemedicine
will play an expanding role in the outpatient management of
neuro-oncology patients, with in-person appointments limited to
pathology requiring detailed physical examination and in persons
who lack telemedicine accessibility.
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